UrinaryN-acetyl-β-glucosaminidase and guanidinoacetic acid levels in epileptic patients treated with anti-epileptic drugs

      This paper is only available as a PDF. To read, Please Download here.


      We investigated potential renal functional impairment induced by chronic use of anti-epileptic drugs (AEDs) in 79 epileptic children. They were divided into five groups: valproic acid (VPA) monotherapy where the serum concentration (SC) of VPA was no less than 60 μg/ml (VPA [SC≥ 60]) (15 cases), VPA monotherapy where the SC VPA was less than 60 μg/ml (VPA [SC< 60]) (29 cases), phenobarbital monotherapy (PB) (7 cases), carbamazepine monotherapy (CBZ) (16 cases), and polytherapy containing VPA (12 cases). Urinalysis (proteinuria and hematuria) and serum creatinine were normal except for two cases of proteinuria and two cases of hematuria. The level of urinary excretion of N-acetyl-β-glucosaminidase (u-NAG) was high in 29% of all patients, and 47% of VPA (SC≥ 60), 38% of CBZ, 25% of polytherapy, and 24% of VPA (SC< 60) groups. There was a significant positive correlation between serum concentration of VPA and u-NAG/urinary creatinine (u-Cr). The level of guanidinoacetic acid (u-GAA) excreted in the urine was normal except in one patient. U-NAG/u-Cr may be a more sensitive marker than u-GAA/u-Cr for renal functional impairment in AED therapy.
      Guanidinoacetic acid (GAA) (), N-Acetyl-β-glucosaminidase (NAG) (), Epilepsy (), Anti-epileptic drug (), Renal functional impairment ()
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lenoir GR
        • Perignon JL
        • Gubler MC
        • Broyer M
        Valproic acid: a possible cause of proximal tubular renal syndrome.
        J Pediatr. 1981; 98: 503-504
        • Lin CY
        • Chiang H
        Sodium-valproate-induced interstitial nephritis.
        Nephron. 1988; 48: 43-46
        • Sheth KJ
        • Casper JT
        • Good TA
        Interstitial nephritis due to phenytoin hypersensitivity.
        J Pediatr. 1977; 91: 438-441
        • Hogg RJ
        • Sawyer M
        • Hecox K
        • Eigenbrodt E
        Carbamazepine induces acute tubulointerstitial nephritis.
        J Pediatr. 1981; 98: 830-832
        • Brajesh NA
        Diphenylhydantoin-induced acute renal failure.
        Nephron. 1977; 18: 249-251
        • Ray-Chaudhuri K
        • Pye IF
        • Boggild M
        Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure.
        Neurology. 1989; 39: 436-438
        • Imai H
        • Nakamoto Y
        • Hirokawa M
        • Akihama T
        • Miura AB
        Carbamazepine-induced granulomatous necrotizing angiitis with acute renal failure.
        Nephron. 1989; 51: 405-408
        • Novo MLP
        • Izumi T
        • Yokota K
        • Fukuyama Y
        Urinary excretion ofN-acetyl-β-glucosaminidase and β-galactosidase by patients with epilepsy.
        Brain Dev. 1993; 15: 157-160
        • Tseng CL
        • Wang PJ
        • Tsau YK
        • Lin MY
        • Shen YZ
        UrinaryN-acetyl-β-glucosaminidase (NAG) in children receiving anti-epileptic drugs.
        Acta Paediatr Sin. 1992; 33: 251-256
        • Ishizaki M
        • Kitamura H
        • Takahashi H
        • Asano H
        • Miura K
        • Okazaki H
        Evaluation of the efficacy of anti-rejection therapy using the quantitative analysis of guanidinoacetic acid (GAA) urinary excretion as a guide.
        in: 4th ed. Guanidines. Plenum, New York1985: 353-363
        • Isoda K
        • Mitarai T
        • Imamura N
        The significance of serum and urinary metabolic function in patients with kidney transplantation.
        in: 4th ed. Guanidines. Vol 2. Plenum, New York1989: 337-343
        • Nako Y
        Urinary excretion of guanidinoacetic acid, β2-microglobulin, andN-acetyl-β-d-glucosaminidase in neonate.
        Kitakanto Medical Journal. 1991; 41 (in Japanese): 545-555
        • Tsubakihara Y
        • Iida N
        • Yuasa S
        Guanidinoacetic acid (GAA) in patients with chronic renal failure (CRF) and diabetes mellitus (DM).
        in: 4th ed. Guanidines. Plenum, New York1985: 306-316
        • Takano Y
        • Gejyo F
        • Shirokane Y
        • Nakajima M
        • Arakawa M
        Urinary excretion rate of guanidinoacetic acid in essential hypertension.
        Nephron. 1988; 48: 167-168
        • Takano Y
        • Aoike I
        • Gejyo F
        • Arakawa M
        Urinary excretion rate of guanidinoacetic acid as a new marker in hypertensive renal damage.
        Nephron. 1989; 52: 273-277
        • Nakayama S
        • Junen M
        • Kiyatake I
        • Koide H
        Urinary guanidinoacetic acid excretion as an indicator of gentamicin nephrotoxicity in rats.
        in: 4th ed. Guanidines. Vol 2. Plenum, New York1989: 303-312
        • Shiraga H
        • Watanabe Y
        • Mori A
        Guanidino compound levels in the serum of healthy adults and epileptic patients.
        Epilepsy Res. 1991; 8: 142-148
        • Noto A
        • Ogawa Y
        • Mori S
        Simple rapid spectrophotometry of urinaryN-acetyl-β-d-glucosaminidase, with use of a new chromogenic substrate.
        Clin Chem. 1983; 29: 1713-1716
        • Shirokane Y
        • Utsushikawa M
        • Nakajima M
        A new enzymic determination of guanidinoacetic acid in urine.
        Clin Chem. 1987; 33: 394-397
        • Sugita O
        • Uchiyama K
        • Yamada T
        • Sato T
        • Okada M
        • Takeuchi K
        Reference value of serum and urine creatinine, and of creatinine clearance by a new enzymatic method.
        Ann Clin Biochem. 1992; 29: 523-528
        • Camfield C
        • Camfield P
        • Smith E
        • Tibbles JAR
        Asymptomatic children with epilepsy: little benefit from screening for anticonvulsant-induced liver, blood, or renal damage.
        Neurology. 1986; 36: 838-841
        • Murakami M
        • Yamamoto H
        • Ueda Y
        • Murakami K
        • Yamauchi K
        Urinary screening of elementary and junior high-school children over a 13-year period in Tokyo.
        Pediatr Nephrol. 1991; 5: 50-53
        • Price RG
        • Dance N
        • Richards B
        • Cattle WR
        The excretion ofN-acetyl-β-glucosaminidase and β-galactosidase following surgery to the kidney.
        Clin Chim Acta. 1970; 27: 57-72
        • Scherberich JE
        Urinary proteins of tubular origin.
        Am J Nephrol. 1990; 10: 43-51
        • Tasaki K
        • Yoshida K
        • Gejyo F
        • Arakawa M
        Metabolism of guanidinoacetic acid in renal tubular tissue culture.
        in: 4th ed. Guanidines. Vol 2. Plenum, New York1989: 323-329
        • McGuire DM
        • Gross MD
        • Elde RP
        • Van Pilum JF
        Localization ofl-arginine-glycine amidinotransferase protein in rat tissue by immunofluorescence microscopy.
        J Histochem Cytochem. 1986; 34: 429-435
        • Margi E
        • Baldoni G
        • Grazi E
        On the biosynthesis of creatinine. Intramitochondrial localization of transaminidase from rat kidney.
        FEBS Lett. 1975; 55: 91-93
        • Kunin CM
        • Chesney RW
        • Craig WA
        • England AC
        • DeAngelis C
        Enzymuria as a marker of renal injury and disease.
        Pediatrics. 1978; 62: 751-760
        • Ponchaut S
        • Draya JP
        • Veitch K
        • Hoof FV
        Influence of chronic administration of valproate on ultrastructure and enzyme content of peroxisomes in rat liver and kidney.
        Biochem Pharmacol. 1991; 41: 1419-1428
        • Doval M
        • Culebras M
        • Lopez-Farre A
        Effect of valproate on lactate and glutamine metabolism by rat renal cortical tubules.
        in: 4th ed. Proc Soc Exp Biol Med. 190. 1989: 357-364
        • Rumbach L
        • Cremel G
        • Marescaux C
        • Warter JM
        • Waksman A
        Valproate-induced hyperammonemia of renal origin.
        Biochem Pharmacol. 1989; 38: 3963-3967
        • Gougoux A
        • Vinay P
        Metabolic effects of valproate on dog renal cortical tubules.
        Can J Physiol Pharmacol. 1989; 67: 88-97